4//SEC Filing
Favorite Annette F 4
Accession 0001562180-23-006659
CIK 0000105770other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 3:46 PM ET
Size
11.0 KB
Accession
0001562180-23-006659
Insider Transaction Report
Form 4
Favorite Annette F
Sr. VP & Chief HR Officer
Transactions
- Sale
Common Stock
2023-08-30$414.91/sh−1,240$514,489→ 14,876.962 total - Exercise/Conversion
Stock Options (Right to buy)
2023-08-30−2,000→ 8,452 totalExercise: $83.47From: 2018-02-21Exp: 2027-02-21→ Common Stock (2,000 underlying) - Sale
Common Stock
2023-08-30$414.19/sh−760$314,788→ 16,116.962 total - Exercise/Conversion
Common Stock
2023-08-30$83.47/sh+2,000$166,940→ 16,876.962 total
Footnotes (3)
- [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $413.58 to $414.57, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $414.58 to $415.08, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F3]This option is fully vested.
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001654975
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 3:46 PM ET
- Size
- 11.0 KB